DOV 102677
Alternative Names: DOV 102,677Latest Information Update: 07 Sep 2010
Price :
$50 *
At a glance
- Originator DOV Pharmaceutical
- Developer DOV Pharmaceutical; Euthymics Bioscience
- Class Antidepressants
- Mechanism of Action Adrenergic receptor antagonists; Dopamine plasma membrane transport protein antagonists; Dopamine uptake inhibitors; Norepinephrine plasma membrane transport protein inhibitors; Serotonin plasma membrane transport protein inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alcoholism
- Discontinued Major depressive disorder
Most Recent Events
- 22 Jul 2010 Euthymics Bioscience acquires DOV Pharmaceutical
- 17 Nov 2007 Phase-I development is ongoing
- 12 Oct 2006 Discontinued - Phase-I for Depression in USA (PO)